Edmond de Rothschild Holding’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-130
| Closed | -$20.4K | – | 583 |
|
|
2024
Q4 | $20.4K | Hold |
130
| – | – | ﹤0.01% | 547 |
|
|
2024
Q3 | $23.1K | Hold |
130
| – | – | ﹤0.01% | 574 |
|
|
2024
Q2 | $21.9K | Hold |
130
| – | – | ﹤0.01% | 608 |
|
|
2024
Q1 | $21.6K | Hold |
130
| – | – | ﹤0.01% | 617 |
|
|
2023
Q4 | $21.5K | Hold |
130
| – | – | ﹤0.01% | 625 |
|
|
2023
Q3 | $20.2K | Hold |
130
| – | – | ﹤0.01% | 632 |
|
|
2023
Q2 | $20.3K | Hold |
130
| – | – | ﹤0.01% | 650 |
|
|
2023
Q1 | $21.1K | Hold |
130
| – | – | ﹤0.01% | 655 |
|
|
2022
Q4 | $20.8K | Hold |
130
| – | – | ﹤0.01% | 713 |
|
|
2022
Q3 | $18K | Hold |
130
| – | – | ﹤0.01% | 747 |
|
|
2022
Q2 | $19K | Hold |
130
| – | – | ﹤0.01% | 732 |
|
|
2022
Q1 | $21K | Hold |
130
| – | – | ﹤0.01% | 741 |
|
|
2021
Q4 | $25K | Sell |
130
-1,400
| -92% | -$270K | ﹤0.01% | 763 |
|
|
2021
Q3 | $309K | Hold |
1,530
| – | – | 0.01% | 490 |
|
|
2021
Q2 | $308K | Hold |
1,530
| – | – | 0.01% | 479 |
|
|
2021
Q1 | $269K | Sell |
1,530
-130
| -8% | -$23.5K | 0.01% | 442 |
|
|
2020
Q4 | $281K | Hold |
1,660
| – | – | 0.01% | 403 |
|
|
2020
Q3 | $269K | Buy |
1,660
+130
| +8% | +$21.1K | 0.01% | 367 |
|
|
2020
Q2 | $249K | Buy |
1,530
+1,400
| +1,077% | +$213K | 0.01% | 352 |
|
|
2020
Q1 | $17K | Sell |
130
-520
| -80% | -$70K | ﹤0.01% | 520 |
|
|
2019
Q4 | $90K | Hold |
650
| – | – | ﹤0.01% | 434 |
|
|
2019
Q3 | $76K | Hold |
650
| – | – | ﹤0.01% | 436 |
|
|
2019
Q2 | $84K | Hold |
650
| – | – | ﹤0.01% | 430 |
|
|
2019
Q1 | $84K | Sell |
650
-600
| -48% | -$75.8K | ﹤0.01% | 445 |
|
|
2018
Q4 | $139K | Hold |
1,250
| – | – | ﹤0.01% | 435 |
|
|
2018
Q3 | $171K | Buy |
1,250
+600
| +92% | +$78K | ﹤0.01% | 459 |
|
|
2018
Q2 | $78K | Sell |
650
-480
| -42% | -$56.6K | ﹤0.01% | 564 |
|
|
2018
Q1 | $136K | Hold |
1,130
| – | – | ﹤0.01% | 524 |
|
|
2017
Q4 | $142K | Sell |
1,130
-460
| -29% | -$58.7K | ﹤0.01% | 541 |
|
|
2017
Q3 | $211K | Sell |
1,590
-360
| -18% | -$46.9K | 0.01% | 477 |
|
|
2017
Q2 | $245K | Buy |
1,950
+220
| +13% | +$26.5K | 0.01% | 457 |
|
|
2017
Q1 | $205K | Sell |
1,730
-60
| -3% | -$7.02K | 0.01% | 481 |
|
|
2016
Q4 | $193K | Sell |
1,790
-1,425
| -44% | -$155K | 0.01% | 495 |
|
|
2016
Q3 | $373K | Buy |
3,215
+315
| +11% | +$35.9K | 0.01% | 433 |
|
|
2016
Q2 | $297K | Sell |
2,900
-1,525
| -34% | -$163K | 0.01% | 448 |
|
|
2016
Q1 | $459K | Sell |
4,425
-10,775
| -71% | -$1.12M | 0.01% | 372 |
|
|
2015
Q4 | $1.93M | Sell |
15,200
-4,405
| -22% | -$540K | 0.05% | 205 |
|
|
2015
Q3 | $2.24M | Buy |
19,605
+6,079
| +45% | +$805K | 0.06% | 198 |
|
|
2015
Q2 | $1.82M | Buy |
+13,526
| New | +$1.8M | 0.04% | 228 |
|
Other funds holding BBH
MIM
TWC
Edmond de Rothschild Holding's BBH Position: Q1 2025 in Review
Edmond de Rothschild Holding sold out of VanEck Biotech ETF (BBH) in Q1 2025, closing a stake of 130 shares — an estimated $20.4K sold.
Edmond de Rothschild Holding first reported a position in BBH in Q2 2015 and held it in 39 quarters. The position peaked at $2.24M in Q3 2015. 104 funds tracked by Wall St. Rank hold BBH as of Q1 2025.
- Edmond de Rothschild Holding reported no remaining VanEck Biotech ETF position as of Q1 2025 after selling out during the quarter.
- Edmond de Rothschild Holding sold 130 VanEck Biotech ETF shares in Q1 2025, an estimated $20.4K.
- Edmond de Rothschild Holding first reported a position in VanEck Biotech ETF in Q2 2015 and held it in 39 quarters.
- Edmond de Rothschild Holding's VanEck Biotech ETF position peaked at $2.24M in Q3 2015.
- 104 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2025.
Based on Edmond de Rothschild Holding's 13F filing for Q1 2025, filed 15 May 2025.